Skip to main content
. 2023 Jun 12;33(5):364–374. doi: 10.1097/CMR.0000000000000903

Fig. 6.

Fig. 6

Longitudinal analysis of ctDNA in patients who acquired resistance. Per-patient plots showing the driver mutations detected over the course of treatment and clinical history in patients developing acquired resistance to treatment. Annotation follows Fig. 4. ctDNA, circulating tumor DNA.